hepatocellular carcinoma

Combination antiviral therapy for hepatitis C

The Food and Drug Administration has approved the use of a single pill containing two different antiviral drugs for the treatment for hepatitis C. It is the first combination pill approved for the disease, and also the first treatment that does not contain interferon or ribavirin. The new hepatitis C drug, called Harvoni, is a mixture …

Combination antiviral therapy for hepatitis C Read More »

Treating hepatitis C by blocking a cellular microRNA

Miravirsen is a drug that binds to and blocks the function of a cellular microRNA called miR-122 that is required for the replication of hepatitis C virus (HCV). Treatment of chimpanzees chronically infected with HCV with this drug leads to suppression of viral replication. The results of a phase 2b human clinical trial in HCV …

Treating hepatitis C by blocking a cellular microRNA Read More »

TWiV 85: Hepatitis C virus with Professor Michael Gale

Hosts: Vincent Racaniello and Michael Gale On episode 85 of the podcast This Week in Virology, Vincent and Michael Gale discuss the origin, pathogenesis, prevention, of hepatitis C virus, and how it evades innate immune responses. This episode is sponsored by Data Robotics Inc. Use the promotion code TWIVPOD to receive $75-$500 off a Drobo. …

TWiV 85: Hepatitis C virus with Professor Michael Gale Read More »

TWiV 80: How much X could a woodchuck chuck?

Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Michael Bouchard Vincent, Alan, and Rich speak with Michael Bouchard about hepatitis B virus discovery, replication, and pathogenesis. This episode is sponsored by Data Robotics Inc. Use the promotion code TWIVPOD to receive $75-$500 off a Drobo. Win a free Drobo S! Contest rules here. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV080.mp3″] …

TWiV 80: How much X could a woodchuck chuck? Read More »

Scroll to Top